A Study to Assess the Safety and Efficacy of Oral LPCN 1154A in Women With Severe PPD

NCT06979544 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

90

Enrollment

INDUSTRY

Sponsor class

Conditions

Depression, Postpartum
Depression, Post-Partum
Postpartum Depression (PPD)
Post-Natal Depression
Peripartum Depression
Postnatal Depression

Interventions

DRUG: LPCN 1154A
DRUG: Placebo

Sponsor

Lipocine Inc.